Anthony H Nguyen

Array ( [id] => 9166804 [patent_doc_number] => 08592482 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-26 [patent_title] => 'CCR3 inhibition for ocular angiogenesis and macular degeneration' [patent_app_type] => utility [patent_app_number] => 13/177986 [patent_app_country] => US [patent_app_date] => 2011-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 6604 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13177986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8814655 [patent_doc_number] => 20130115700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-09 [patent_title] => 'METHOD FOR TRANSFECTING NUCLEIC ACID TO CELL AND NUCLEIC ACID COMPLEX' [patent_app_type] => utility [patent_app_number] => 13/808695 [patent_app_country] => US [patent_app_date] => 2011-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8048 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13808695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15163701 [patent_doc_number] => 10487332 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-26 [patent_title] => Immunisation of large mammals with low doses of RNA [patent_app_type] => utility [patent_app_number] => 13/808153 [patent_app_country] => US [patent_app_date] => 2011-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 18178 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13808153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8830110 [patent_doc_number] => 20130131155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-23 [patent_title] => 'Optimized In Vivo Delivery System with Endosomolytic Agents for Nucleic Acid Conjugates' [patent_app_type] => utility [patent_app_number] => 13/703965 [patent_app_country] => US [patent_app_date] => 2011-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19852 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13703965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9034329 [patent_doc_number] => 20130236968 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-12 [patent_title] => 'MULTIFUNCTIONAL COPOLYMERS FOR NUCLEIC ACID DELIVERY' [patent_app_type] => utility [patent_app_number] => 13/805991 [patent_app_country] => US [patent_app_date] => 2011-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30588 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13805991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8841161 [patent_doc_number] => 20130136789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-30 [patent_title] => 'AGENT FOR TREATING RENAL FIBROSIS' [patent_app_type] => utility [patent_app_number] => 13/704437 [patent_app_country] => US [patent_app_date] => 2011-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10368 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13704437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8927595 [patent_doc_number] => 20130183355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-18 [patent_title] => 'DELIVERY OF SELF-REPLICATING RNA USING BIODEGRADABLE POLYMER PARTICLES' [patent_app_type] => utility [patent_app_number] => 13/808245 [patent_app_country] => US [patent_app_date] => 2011-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 29976 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13808245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7510893 [patent_doc_number] => 20110256621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'COLLOIDAL MAGNETIC NANOBIOPARTICLES FOR CYTOTOXICITY AND DRUG DELIVERY' [patent_app_type] => utility [patent_app_number] => 13/151699 [patent_app_country] => US [patent_app_date] => 2011-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16162 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20110256621.pdf [firstpage_image] =>[orig_patent_app_number] => 13151699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8708018 [patent_doc_number] => 20130065308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'CATIONIC LIPIDS' [patent_app_type] => utility [patent_app_number] => 13/698804 [patent_app_country] => US [patent_app_date] => 2011-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 29029 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13698804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8829251 [patent_doc_number] => 20130130297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-23 [patent_title] => 'INDUCTION OF A MATURE HEPATOCYTE PHENOTYPE' [patent_app_type] => utility [patent_app_number] => 13/697233 [patent_app_country] => US [patent_app_date] => 2011-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10351 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13697233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7721164 [patent_doc_number] => 20120010499 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'USE OF NANOPARTICLES FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/101960 [patent_app_country] => US [patent_app_date] => 2011-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5956 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20120010499.pdf [firstpage_image] =>[orig_patent_app_number] => 13101960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11225527 [patent_doc_number] => 09453241 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-27 [patent_title] => 'AAV-mediated subcellular targeting of heterologous rhodopsins in retinal ganglion cells' [patent_app_type] => utility [patent_app_number] => 13/696252 [patent_app_country] => US [patent_app_date] => 2011-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 26528 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13696252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8949977 [patent_doc_number] => 20130195757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'SPARC BINDING APTAMERS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/695367 [patent_app_country] => US [patent_app_date] => 2011-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 16001 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13695367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9099092 [patent_doc_number] => 08562964 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-22 [patent_title] => 'Polymalic acid-based multifunctional drug delivery system' [patent_app_type] => utility [patent_app_number] => 13/097364 [patent_app_country] => US [patent_app_date] => 2011-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 14250 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13097364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10095880 [patent_doc_number] => 09132175 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-15 [patent_title] => 'Bacillus based delivery system and methods of use' [patent_app_type] => utility [patent_app_number] => 13/089015 [patent_app_country] => US [patent_app_date] => 2011-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 27 [patent_no_of_words] => 21080 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 278 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13089015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8054001 [patent_doc_number] => 20120076735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'Nanoparticles for Extravascular Administration' [patent_app_type] => utility [patent_app_number] => 13/071067 [patent_app_country] => US [patent_app_date] => 2011-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19213 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20120076735.pdf [firstpage_image] =>[orig_patent_app_number] => 13071067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9762070 [patent_doc_number] => 08846390 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-30 [patent_title] => 'Methods of conditioning sheet bioprosthetic tissue' [patent_app_type] => utility [patent_app_number] => 13/069827 [patent_app_country] => US [patent_app_date] => 2011-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 25 [patent_no_of_words] => 10214 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13069827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7696618 [patent_doc_number] => 20110229972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'COMPOSITIONS AND METHODS FOR MATERIAL TRANSFER INTO CELLS' [patent_app_type] => utility [patent_app_number] => 13/052621 [patent_app_country] => US [patent_app_date] => 2011-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11481 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229972.pdf [firstpage_image] =>[orig_patent_app_number] => 13052621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11229842 [patent_doc_number] => 09457054 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-04 [patent_title] => 'Method for using a Bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions' [patent_app_type] => utility [patent_app_number] => 13/582359 [patent_app_country] => US [patent_app_date] => 2011-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5758 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13582359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8586220 [patent_doc_number] => 20130005041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'Agent for Improving Gene Transfer Efficiency to Mammalian Cells' [patent_app_type] => utility [patent_app_number] => 13/583847 [patent_app_country] => US [patent_app_date] => 2011-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6974 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13583847 [rel_patent_id] =>[rel_patent_doc_number] =>)